Related Experiment Video
Updated: Aug 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Thrombophilia in coronary artery disease: a double jeopardy
1Institute of Immunohaematology (ICMR), Mumbai, India. mohanty@bom5.vsnl.net.in
Insights
Thrombophilia, an increased thrombosis risk, involves haemostasis disruption. Investigating thrombophilia in Indian young myocardial infarction patients is crucial due to rising cases and lack of conventional risk factors.
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Thrombophilia signifies an elevated risk of thrombosis, stemming from genetic or environmental haemostasis perturbations.
- Coronary artery disease (CAD) pathogenesis involves atheroma development, leading to angina and myocardial infarction (MI).
- Emerging research explores blood coagulation factors, natural anticoagulants, platelet antigens, homocysteine, and lipoprotein (a) in arterial thrombosis and CAD risk.
Purpose of the Study:
- To investigate the role of thrombophilia in young Indian patients experiencing myocardial infarction (MI).
- To address the rising incidence of MI in young Indians lacking traditional risk factors.
- To evaluate the significance and cost-effectiveness of thrombophilia investigations in India.
Main Methods:
- Review of existing literature on thrombophilia and its association with arterial thrombosis.
- Analysis of studies on coagulation factors, natural anticoagulants, and other risk factors in CAD.
- Consideration of clinical trial data on thrombophilia management.
Main Results:
- Contradictory findings exist regarding the role of various factors in arterial thrombosis and CAD.
- A notable increase in young MI patients in India is observed, often without conventional risk factors.
- Limited studies on thrombophilia status among Indian populations highlight a knowledge gap.
Conclusions:
- Thrombophilia is a significant consideration in unexplained MI, particularly in younger populations.
- Cost-effective selection of thrombophilia investigations is paramount for developing countries like India.
- Further research is needed to clarify the role of thrombophilia in the Indian context and guide management strategies.
Abstract:
Thrombophilia can be defined as an increased risk of thrombosis. The central event to the pathogenesis of any thrombotic episode is the perturbation of haemostasis, the cause of which may be genetic or environmental. The clinical manifestations of the chronic development of coronary artery atheroma are angina and acute myocardial infarction. In recent years literature is emerging on the role of different factors of blood coagulation in arterial thrombosis. Different coagulation factors, natural anticoagulants, platelet antigens and other factors such as homocysteine, lipoprotein (a), have been studied as risk factors for coronary artery disease (CAD). The results of many of these studies are contradictory. In India, there is an alarming rise in the number of young patients with myocardial infarction (MI) and an interesting feature is that a large majority of these patients lack the conventional risk factors. There have been scattered studies on the thrombophilia status among Indians. The management of thrombophilia can be done by a regimen of different drugs which has been evaluated in different clinical trials. Since the cost of thrombophilia investigations is quite phenomenal for a developing country like India, the selection of these investigations assumes an utmost importance.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease II: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease IV: Preventive Measures
Venous Thrombosis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
